RA CAPITAL MANAGEMENT, L.P.
Director
- Shares
- 33,800
- Price
- $7.46
- Value
- $252,148
SION
6 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$21,835,018
0 buyers · 6 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$151,094,363
13 distinct insiders
Highlighted alerts
47
53 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SION overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest on June 17, 2027, subject to the Reporting Person's continued service with the Issuer as of the vesting date. Represents a grant of RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest upon the achievement of a designated performance milestone, subject to the Reporting Person's continued service with the Issuer as of the vesting date. The exercise price of the option is $7.18 per share, representing the fair market value per share of the Issuer's Common Stock on September 17, 2026 (the "Repricing Date"). Unless otherwise provided by the Issuer's board of directors or its compensation committee, if the option is exercised before the applicable retention period ends, the exercise price will revert to its original exercise price. The retention period begins on the Repricing Date and ends on the earliest of (i) the 18-month anniversary of the Repricing Date (March 17, 2028), (ii) a Sale Event (as defined in the Sionna Therapeutics, Inc. 2025 Stock Option and Incentive Plan (the "2025 Plan")) or (iii) certain qualifying terminations of service. Effective on the Repricing Date, the Issuer's board of directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. This stock option award was issued pursuant to the 2025 Plan, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on the applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
Voluntary purchases and sales; administrative noise stays hidden.
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Fitzpatrick Jennifer
Chief Legal Officer
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Fitzpatrick Jennifer
Chief Legal Officer
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
TPG GP A, LLC
10% owner
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
Fitzpatrick Jennifer
Chief Legal Officer
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
ORBIMED ADVISORS LLC
Director
Thompson Peter A.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
RA CAPITAL MANAGEMENT, L.P.
Director
Cloonan Michael
President & CEO
Cloonan Michael
President & CEO
Cloonan Michael
President & CEO
Cloonan Michael
President & CEO
Booth Bruce
Director
Booth Bruce
Director
Booth Bruce
Director
Booth Bruce
Director
Booth Bruce
Director
Booth Bruce
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 33,800 | $7.46 | $252,148 | |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 3,415,011 | $6.32 | $21,582,870 | |
| Jul 07, 2026 | Thompson Peter A. Director | Sale | 85,918 | $44.86 | $3,854,281 | |
| Jul 07, 2026 | ORBIMED ADVISORS LLC Director | Sale | 85,918 | $44.86 | $3,854,281 | |
| Jul 06, 2026 | Fitzpatrick Jennifer Chief Legal Officer | Sale | 10,250 | $43.60 | $446,862 | |
| Jun 30, 2026 | Thompson Peter A. Director | Sale | 115,844 | $45.50 | $5,270,902 | |
| Jun 30, 2026 | ORBIMED ADVISORS LLC Director | Sale | 115,844 | $45.50 | $5,270,902 | |
| May 27, 2026 | Thompson Peter A. Director | Sale | 101 | $44.49 | $4,493 | |
| May 27, 2026 | ORBIMED ADVISORS LLC Director | Sale | 101 | $44.49 | $4,493 | |
| May 11, 2026 | Thompson Peter A. Director | Sale | 184,639 | $46.22 | $8,534,015 | |
| May 11, 2026 | ORBIMED ADVISORS LLC Director | Sale | 184,639 | $46.22 | $8,534,015 | |
| May 08, 2026 | Thompson Peter A. Director | Sale | 59,767 | $44.58 | $2,664,413 | |
| May 08, 2026 | ORBIMED ADVISORS LLC Director | Sale | 59,767 | $44.58 | $2,664,413 | |
| May 07, 2026 | Thompson Peter A. Director | Sale | 48,546 | $44.61 | $2,165,637 | |
| May 07, 2026 | ORBIMED ADVISORS LLC Director | Sale | 48,546 | $44.61 | $2,165,637 | |
| Apr 18, 2026 | Thompson Peter A. Director | Sale | 2,948 | $44.52 | $131,245 | |
| Apr 18, 2026 | ORBIMED ADVISORS LLC Director | Sale | 2,948 | $44.52 | $131,245 | |
| Apr 17, 2026 | Thompson Peter A. Director | Sale | 52,397 | $44.68 | $2,341,098 | |
| Apr 17, 2026 | ORBIMED ADVISORS LLC Director | Sale | 52,397 | $44.68 | $2,341,098 | |
| Apr 16, 2026 | Thompson Peter A. Director | Sale | 226,906 | $45.34 | $10,287,918 | |
| Apr 16, 2026 | ORBIMED ADVISORS LLC Director | Sale | 226,906 | $45.34 | $10,287,918 | |
| Apr 15, 2026 | Thompson Peter A. Director | Sale | 235,863 | $44.64 | $10,528,924 | |
| Apr 15, 2026 | ORBIMED ADVISORS LLC Director | Sale | 235,863 | $44.64 | $10,528,924 | |
| Apr 14, 2026 | Thompson Peter A. Director | Sale | 47,814 | $44.51 | $2,128,201 | |
| Apr 14, 2026 | ORBIMED ADVISORS LLC Director | Sale | 47,814 | $44.51 | $2,128,201 | |
| Mar 05, 2026 | Fitzpatrick Jennifer Chief Legal Officer | Sale | 10,250 | $33.86 | $347,019 | |
| Feb 03, 2026 | Thompson Peter A. Director | Sale | 29,063 | $44.58 | $1,295,629 | |
| Feb 03, 2026 | ORBIMED ADVISORS LLC Director | Sale | 29,063 | $44.58 | $1,295,629 | |
| Feb 02, 2026 | Thompson Peter A. Director | Sale | 1,890 | $44.57 | $84,237 | |
| Feb 02, 2026 | ORBIMED ADVISORS LLC Director | Sale | 1,890 | $44.57 | $84,237 | |
| Jan 22, 2026 | TPG GP A, LLC 10% owner | Sale | 250,000 | $40.00 | $10,000,000 | |
| Dec 24, 2025 | ORBIMED ADVISORS LLC Director | Sale | 33,356 | $44.55 | $1,486,010 | |
| Dec 24, 2025 | Thompson Peter A. Director | Sale | 33,356 | $44.55 | $1,486,010 | |
| Dec 19, 2025 | ORBIMED ADVISORS LLC Director | Sale | 875 | $44.49 | $38,929 | |
| Dec 19, 2025 | Thompson Peter A. Director | Sale | 875 | $44.49 | $38,929 | |
| Dec 18, 2025 | ORBIMED ADVISORS LLC Director | Sale | 100 | $44.49 | $4,449 | |
| Dec 18, 2025 | Thompson Peter A. Director | Sale | 100 | $44.49 | $4,449 | |
| Dec 17, 2025 | ORBIMED ADVISORS LLC Director | Sale | 900 | $44.50 | $40,050 | |
| Dec 17, 2025 | Thompson Peter A. Director | Sale | 900 | $44.50 | $40,050 | |
| Dec 05, 2025 | Fitzpatrick Jennifer Chief Legal Officer | Sale | 10,250 | $40.52 | $415,330 | |
| Nov 26, 2025 | ORBIMED ADVISORS LLC Director | Sale | 1,600 | $44.49 | $71,184 | |
| Nov 26, 2025 | Thompson Peter A. Director | Sale | 1,600 | $44.49 | $71,184 | |
| Nov 25, 2025 | ORBIMED ADVISORS LLC Director | Sale | 11,890 | $44.60 | $530,294 | |
| Nov 25, 2025 | Thompson Peter A. Director | Sale | 11,890 | $44.60 | $530,294 | |
| Nov 24, 2025 | ORBIMED ADVISORS LLC Director | Sale | 94,583 | $44.54 | $4,212,727 | |
| Nov 24, 2025 | Thompson Peter A. Director | Sale | 94,583 | $44.54 | $4,212,727 | |
| Nov 21, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 9,924 | $39.50 | $391,998 | |
| Nov 21, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 1,210 | $39.50 | $47,795 | |
| Nov 21, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 7,609 | $39.50 | $300,556 | |
| Nov 21, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 6,440 | $39.50 | $254,380 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 604 | $40.50 | $24,462 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 512 | $40.50 | $20,736 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 788 | $40.50 | $31,914 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 96 | $40.50 | $3,888 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 947 | $39.89 | $37,776 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 801 | $39.89 | $31,952 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 1,235 | $39.89 | $49,264 | |
| Nov 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 150 | $39.89 | $5,984 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 9 | $40.61 | $365.49 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 8 | $40.61 | $324.88 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 12 | $40.61 | $487.32 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 2 | $40.61 | $81.22 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 14,325 | $40.01 | $573,143 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 12,126 | $40.01 | $485,161 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 18,684 | $40.01 | $747,547 | |
| Nov 19, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 2,276 | $40.01 | $91,063 | |
| Nov 18, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 2,092 | $39.57 | $82,780 | |
| Nov 18, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 1,770 | $39.57 | $70,039 | |
| Nov 18, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 2,728 | $39.57 | $107,947 | |
| Nov 18, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 332 | $39.57 | $13,137 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 433 | $42.10 | $18,229 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 53 | $42.10 | $2,231 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 10,707 | $41.05 | $439,522 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 9,063 | $41.05 | $372,036 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 13,964 | $41.05 | $573,222 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 1,701 | $41.05 | $69,826 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 13,734 | $40.20 | $552,107 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 11,626 | $40.20 | $467,365 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 331 | $42.10 | $13,935 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 280 | $42.10 | $11,788 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 17,913 | $40.20 | $720,103 | |
| Nov 17, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 2,182 | $40.20 | $87,716 | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 10,476 | $39.58 | $414,640 | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 17,118 | $39.58 | $677,530 | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 31,392 | $39.58 | $1,242,495 | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 3,624 | $39.58 | $143,438 | |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 107,941 | $39.50 | $4,263,670 | |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 66,672 | $39.50 | $2,633,544 | |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 122,271 | $39.50 | $4,829,705 | |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 14,116 | $39.50 | $557,582 | |
| Oct 21, 2025 | Cloonan Michael President & CEO | Sale | 33,532 | $37.31 | $1,251,079 | |
| Oct 21, 2025 | Cloonan Michael President & CEO | Sale | 22,895 | $36.60 | $837,957 | |
| Oct 21, 2025 | Cloonan Michael President & CEO | Sale | 30,049 | $35.63 | $1,070,646 | |
| Oct 21, 2025 | Cloonan Michael President & CEO | Sale | 13,324 | $34.44 | $458,879 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 17 | $36.42 | $619.14 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 83 | $36.42 | $3,023 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 5,316 | $35.69 | $189,728 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 25,327 | $35.69 | $903,921 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 1,210 | $34.91 | $42,241 | |
| Oct 21, 2025 | Booth Bruce Director | Sale | 5,763 | $34.91 | $201,186 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.